Stephen F. Flatt - Nov 5, 2021 Form 4 Insider Report for NATIONAL HEALTHCARE CORP (NHC)

Role
CEO, Director
Signature
/s/ Stephen F. Flatt by Kristina R. Hulsey, P.O.A.
Stock symbol
NHC
Transactions as of
Nov 5, 2021
Transactions value $
-$32,030
Form type
4
Date filed
11/9/2021, 04:59 PM
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NHC Shares of Common Stock held in my name Options Exercise $2.92M +40K +78.85% $72.94 90.7K Nov 5, 2021 Direct F1
transaction NHC Shares of Common Stock held in my name Tax liability -$2.95M -38.6K -42.58% $76.35 52.1K Nov 5, 2021 Direct F2, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NHC Option to Purchase Common Stock Options Exercise $0 -40K -88.89% $0.00 5K Nov 5, 2021 Common Stock 45K $72.94 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These stock options were granted pursuant to the 2010 Omnibus Equity Incentive Plan on May 9, 2017. On February 11, 2021, the Compensation Committee amended the options to grant the ability to exercise up to 100% of these options, with any shares issued upon exercise to be held as restricted stock until February 9, 2022, the original vesting date. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).
F2 Shares were withheld by the Company to pay the exercise price and withholding tax obligations.
F3 Total amount of shares beneficially owned following transactions reported on this form.